title: [Experience with the use of phospholipid preparations in the combined treatment of bronchial asthma].
abstract: The authors report the results of a single-blind randomized placebo-controlled study of the efficacy and safety of inhalation of phospholipid nanoparticles in patients with bronchial asthma. They give evidence of the statistically significant positive effect of the proposed therapeutic modality on the clinical status of the patients and lung functional tests. No clinically significant adverse events were documented during the study.
authors.forename: A V
authors.initials: AV
authors.lastname: Lisitsa
authors.forename: S K
authors.initials: SK
authors.lastname: Soodaeva
authors.forename: I A
authors.initials: IA
authors.lastname: Klimanov
authors.forename: S E
authors.initials: SE
authors.lastname: Mikhaĭlov
authors.forename: A V
authors.initials: AV
authors.lastname: Aver'ianov
authors.forename: O P
authors.initials: OP
authors.lastname: Kuzovlev
mesh_terms: D000280:Administration, Inhalation; D000368:Aged; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume / Q000187:drug effects*; D019695:Glycyrrhizic Acid / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009330:Nebulizers and Vaporizers; D010713:Phosphatidylcholines / Q000008:administration & dosage*; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D010713:Phosphatidylcholines; C504418:Phosphogliv; D019695:Glycyrrhizic Acid